| Question 11 | Carriage of carbon dioxide and of oxygen in the blood |
| Question 2 |
| Question 16 | Structure and function of the upper airways: anatomy of the larynx |
| Question 11 | Drugs used to treat asthma: aminophylline |
| Question 6 | |
| Question 1 | Limitations of pulse oximetry as compared to the ABG SaO2 |
| Question 18 | |
| Question 14 | |
| Question 10 | Pharmacology of drugs used to treat asthma - salbutamol |
| Question 8 | |
| Question 4 | |
| Question 3 | End-tidal capnometry, including sources of error |
| Question 15 | Anatomy and physiology of the pulmonary circulation |
| Question 4 |
| Question 19 | Physiological factors that affect PaCO2. |
| Question 4 | |
| Question 3 |
| Question 12 | |
| Question 10 |
| Question 17 | |
| Question 15 | |
| Question 2 |
| Question 17 | Pulmonary vasodilators: inhaled nitric oxide (NO). |
| Question 14 | Anatomy of the airway: the larynx |
| Question 13 | Pulmonary circulation: anatomical and physiological features |
| Question 11 | |
| Question 8 | |
| Question 2 | Functional residual capacity: its functions and influences |
| Question 18 | |
| Question 13 | |
| Question 6 | Neonatal respiratory physiology (vs. adult) |
| Question 1 |
| Question 17 | |
| Question 10 | End-tidal capnometry: calibration, sources of error and limitations. |
| Question 8 | |
| Question 7 | Closing capacity: definition, clinical significance, and factors which alter it. |
| Question 5 |
| Question 20 | |
| Question 19 | |
| Question 16 | |
| Question 12 | Pharmacology of drugs used to treat asthma: salbutamol vs. ipratropium bromide |
| Question 14 | |
| Question 5 | Carriage of carbon dioxide in the blood |
| Question 3 |
| Question 3 | |
| Question 1 |
| Question 24 | Functional Residual capacity: what is it, and how is it measured? |
| Question 18 | |
| Question 6 |
| Question 21 | |
| Question 14 | |
| Question 8 | Functional residual capacity: what happens if it is reduced by 1L |
| Question 7 |
| Question 24 | |
| Question 22 | |
| Question 6 | |
| Question 5 | |
| Question 4 |
| Question 15 | |
| Question 3 | |
| Question 2 | |
| Question 1 | Determinants of DO2 and oxygen-carrying capacity of blood |
| Question 21 | Muscles involved in respiration - the diaphragm |
| Question 13 | |
| Question 5 | |
| Question 4 | Functional Residual capacity: what is it, and how is it measured? |
| Question 17 | |
| Question 13 | Carriage of carbon dioxide in the blood |
| Question 1 |
| Question 18 | Differences between haemoglobin and myoglobin |
| Question 17 | |
| Question 11 | |
| Question 5 | |
| Question 3 |
| Question 15 | |
| Question 13 |
| Question 23 | |
| Question 7 | |
| Question 5 |
| Question 21 | |
| Question 11 |
| Question 21 | Pharmacology of CO2: physiological consequences of hypercapnea |
| Question 6 | |
| Question 3 | |
| Question 1 | Carriage of carbon dioxide and of oxygen in the blood |
| Question 20 | |
| Question 6 | Carriage of carbon dioxide in the blood |
| Question 1 |
| Question 18 | |
| Question 7 |
| Question 14 | |
| Question 2 | Muscles involved in respiration - the diaphragm |
| Question 1 | Oxygen storage in the human body: effects of pre-oxygenation |
| Question 15 | Physiological consequences of decreasing Functional Residual Capacity (FRC) |
| Question 13 | |
| Question 14 | |
| Question 1 |
| Question 7(p.2) | |
| Question 9 | |
| Question 6 |
| Question 7(p.2) | |
| Question 4(p.2) | |
| Question 10 | Gas exchange at altitude, and physiological adaptation to it. |
| Question 6 |
| Question 6(p.2) | |
| Question 5(p.2) | |
| Question 9 | |
| Question 6 |
| Question 12(p.2) | |
| Question 5(p.2) |
| Question 11 | |
| Question 6 | |
| Question 3 |
| Question 11(p.2) | |
| Question 1(p.2) |